Clinical Trials Browser

Phase 2 × liposomal doxorubicin × Other hematologic neoplasm × Clear all

NCT03678883 2024-11-07

9-ING-41 in Patients with Advanced Cancers

Phase 2 Active not recruiting

BreastCNSGastrointestinalGenitourinaryLymphoidOther hematologic neoplasmSarcomaThoracic

Bone Neoplasms, Breast Neoplasms, Glioma, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neoplasm Metastasis, Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms, Leukemia-Lymphoma, Adult T-Cell

NCT01736943 2021-02-24

Bortezomib and Doxil for the Treatment of Patients With Acute Myelogenous Leukemia

Phase 2 Completed

25 enrolled 9 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00074490 2018-12-31

Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers

Phase 2 Terminated

442 enrolled 17 charts

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders

NCT01328236 2011-09-22

Bortezomib

Phase 2 Unknown

Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell, Multiple Myeloma